Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Losing the Same Weight Didn’t Produce the Same Health Benefits (opens in a new tab)

scitechdaily.com · 2026-09-27

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. 3 other points were not covered by the paper.

  • 3 supported
  • 1 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Three of seven check out. Three claims the study doesn't address.

  • 3 supported
  • 1 overstated
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The abstract reports no between-group differences in LDL-cholesterol, apolipoprotein B, or 24-hour plasma triglyceride concentrations.

    This is a material counterbalance to broad claims about superior metabolic health from the ketogenic diet. The story presentation does not mention that key lipid and lipoprotein risk markers did not differ among diets.

    From Randomized clinical trial, three-arm dietary intervention; Randomized clinical trial (three diet arms; matched ~10% weig

  • At abstract depth, several methodological details are unavailable, including specific measurement methods, sample sizes per arm or endpoint, intervention duration, adherence metrics, and randomization/allocation details.

    The story presents detailed numerical claims and a causal framing without noting these abstract-level limitations. Some limitations may be addressed in the full paper, but they are not verifiable from the supplied abstract profile.

    From Randomized clinical trial, three-arm dietary intervention; randomized clinical trial, three diet arms; matched ~10% weig

  • At abstract depth, exact quantitative magnitudes for liver-fat reduction, 24-hour glucose reduction, and prediabetes reversal are not provided.

    The story reports exact values for these outcomes, but the supplied paper profile only supports qualitative direction for intrahepatic triglyceride and glycemic outcomes and does not mention prediabetes reversal.

    From Randomized clinical trial, three-arm dietary intervention; randomized clinical trial, three diet arms; matched ~10% weig

6 things the story did carry across
  • The paper is a randomized clinical trial comparing very-low-carbohydrate ketogenic, Mediterranean, and very-low-fat plant-forward diets in adults with metabolically unhealthy obesity, prediabetes, and hepatic steatosis.
  • The diets were evaluated in the context of similar moderate weight loss of about 10%, not as unrestricted diet-composition changes independent of weight loss.
  • The very-low-carbohydrate ketogenic diet produced greater improvements in hepatic metabolic function, including hepatic insulin sensitivity, intrahepatic triglyceride, and de novo lipogenesis, than the other diet groups.
  • Glycemic measures, including HbA1c and 24-hour serial plasma glucose and insulin, decreased most in the very-low-carbohydrate group.
  • Muscle insulin sensitivity improved by approximately 50% in all groups, indicating an outcome where diet composition did not distinguish the groups.
  • The findings apply to adults with metabolically unhealthy obesity, prediabetes, and hepatic steatosis, so generalization beyond that population is limited.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoTest whether diet macronutrient composition (very-low-carbohydrate ketogenic vs Mediterranean vs very-low-fat plant-forward) differentially affects cardiometabolic outcomes when ~10% weight loss is achieved in adults with metabolically unhealthy obesity (prediabetes and hepatic steatosis).Randomized clinical trial, three-arm dietary interventionExpand

In plain English

Randomized clinical trial in adults with metabolically unhealthy obesity (prediabetes and hepatic steatosis) comparing three diets (very-low-carbohydrate ketogenic, Mediterranean, and very-low-fat plant-forward) that achieved similar moderate (~10%) weight loss; metabolic outcomes (muscle and hepatic insulin sensitivity, intrahepatic triglyceride, hepatic de novo lipogenesis, glycemic measures, and blood lipids) were compared across diet arms. The very-low-carbohydrate diet produced larger improvements in hepatic insulin sensitivity and several hepatic/glycemic outcomes, while muscle insulin sensitivity improved similarly across groups and LDL-C, apolipoprotein B, and 24-h triglycerides did not differ between diets.

Key findings

  • Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
  • Hepatic insulin sensitivity increased two-to-three-fold more in the very-low-carbohydrate group than in the Mediterranean and very-low-fat groups (p < 0.001).2–3-fold greater increase vs other groups; p < 0.001
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
What this piece can’t prove
  • Population described is adults with metabolically unhealthy obesity (prediabetes and hepatic steatosis); findings may not generalize beyond this population (implicit from study population description).

2 further details could not be confirmed from the summary.

2human in vivoQuantify and compare changes in hepatic metabolic function with weight loss across diets (hepatic insulin sensitivity, intrahepatic triglyceride, de novo lipogenesis), emphasizing whether very-low-carbohydrate diet yields greater hepatic benefits.randomized clinical trial, three diet arms; matched ~10% weight loss targetExpand

In plain English

Abstract of a randomized clinical trial in people with metabolically unhealthy obesity reports that ~10% weight loss produced greater improvements in hepatic metabolic function (hepatic insulin sensitivity, intrahepatic triglyceride content, and hepatic de novo lipogenesis) for a very-low-carbohydrate ketogenic diet than for Mediterranean or very-low-fat plant-forward diets.

Key findings

  • Hepatic insulin sensitivity increased two-to-three-fold more in the very-low-carbohydrate group than in the Mediterranean or very-low-fat groups (p < 0.001).two-to-three-fold greater (p < 0.001)
  • Intrahepatic triglyceride content decreased most in the very-low-carbohydrate group compared with the other diet groups.
“...caused a two-to-three-fold greater increase in hepatic insulin sensitivity in the very-low-carbohydrate group than the other groups (p < 0.001).”
What this piece can’t prove

4 further details could not be confirmed from the summary.

3human in vivoAssess whether lipid/lipoprotein risk markers differ by diet after matched weight loss (LDL-C, apolipoprotein B, 24-hour triglycerides).Randomized clinical trial (three diet arms; matched ~10% weight loss)Expand

In plain English

In this randomized clinical trial of three diets producing matched ~10% weight loss in people with metabolically unhealthy obesity, the abstract reports no between-group differences for LDL-cholesterol, apolipoprotein B, or 24-hour plasma triglyceride concentrations.

Key findings

  • After matched ~10% weight loss, the study reports no between-group differences in LDL-cholesterol, apolipoprotein B, or 24-hour plasma triglyceride concentrations across the three diet arms.
“There were no differences among groups in LDL-cholesterol, apolipoprotein B, or 24-h plasma triglyceride concentrations.”
What this piece can’t prove

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 36 candidate papers

Candidate

Author response for "Deep Profiling Reveals Coordinated Remodeling of Ganglioside Metabolism in MCF-7 Breast Cancer Cell Line"

2026 · Crossref

Candidate

Attention-Driven Rendering and Interface Adaptation Using Eye-Tracking Data

Journal of Science & Technology · 2026 · Crossref

And 30 more candidates considered.